Knocking Off SOCS Genes in the Mammary Gland

Kate D. Sutherland, Geoffrey J. Lindeman and Jane E. Visvader

volume 6 | issue 7

1 April 2007
Pages: 799 - 803

We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:

Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Suppressors of cytokine signaling (SOCS) proteins are critical regulators of cytokinemediated responses in diverse tissues. In the mammary gland, signal transduction pathways elicited by cytokines and hormones have been shown to control distinct stages of development. In vivo evidence points to essential roles for Socs1 and Socs2 as key physiological attenuators of prolactin receptor (PRLR) signaling during pregnancy and lactogenesis. Recently, Socs3 has been shown to be a critical regulator of involution, the coordinated process of programmed cell death and tissue remodelling that is initiated after the cessation of lactation. This review will predominantly focus on the antiapoptotic function of Socs3 during mammary gland involution in which it acts as a key attenuator of Stat3-mediated signal transduction. Perturbation of this pathway leads to an increase in the levels of c-myc and its likely target genes, p53, bax and E2F-1, providing evidence that c-myc is a central effector of apoptosis during involution.

Authors

Kate D. Sutherland

The Netherlands Cancer Institute, Amsterdam, Netherlands

Geoffrey J. Lindeman

The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia

Jane E. Visvader